Summary
HCA Healthcare, Inc. (HCA) filed an 8-K on July 24, 2026, to disclose its financial results for the second quarter ended June 30, 2026, through an accompanying press release. While the 8-K itself does not provide specific financial figures, it directs investors to Exhibit 99.1, the press release, for detailed operational and financial performance. This filing is crucial for investors seeking to understand HCA's recent performance, as it typically contains key metrics such as revenue, earnings per share, and operational statistics that drive the company's valuation.
Key Highlights
- 1HCA Healthcare announced its second quarter 2026 results of operations on July 24, 2026, via a press release filed with the SEC.
- 2The press release (Exhibit 99.1) is the primary source for detailed financial and operational performance for the quarter ended June 30, 2026.
- 3HCA's Board of Directors declared a quarterly cash dividend of $0.78 per share.
- 4The dividend is scheduled to be paid on September 30, 2026.
- 5Shareholders of record as of September 16, 2026, will be eligible to receive the dividend.
- 6The filing also includes the Cover Page Interactive Data File in Inline XBRL format.
Frequently Asked Questions
The specific financial results for the second quarter ended June 30, 2026, are detailed in the press release filed as Exhibit 99.1 to this 8-K filing, dated July 24, 2026. Investors should refer to this exhibit for comprehensive performance data.
HCA Healthcare's Board of Directors has declared a quarterly cash dividend of $0.78 per share. This dividend will be paid on September 30, 2026.
Shareholders who are of record at the close of business on September 16, 2026, will be eligible to receive the quarterly cash dividend of $0.78 per share.